Status:
UNKNOWN
Effect of Lactoferrin in Pneumonia Treatment
Lead Sponsor:
Assiut University
Conditions:
Pneumonia
Eligibility:
All Genders
1-18 years
Phase:
NA
Brief Summary
Pneumonia is defind as the inflammation of lung tissue caused by an infectious agent that results in acute respiratory signs and symptoms. Community acquired pneumonia (CAP) is a major cause of morbid...
Detailed Description
Lactoferrin (LF) is iron-binding glycoprotein of the transferrin family that is expressed and secreted by glandular cells and is found in most body fluids . It appears at especially high concentration...
Eligibility Criteria
Inclusion
- Pneumonia patients
- from the age of one month to the age of 18 years .
Exclusion
- Neonates and any children with :
- immune deficiency
- congenital heart disease
- neuromascular disorder
- genetic syndromes
Key Trial Info
Start Date :
August 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2024
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT05431023
Start Date
August 1 2022
End Date
August 1 2024
Last Update
June 24 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.